ImmunityBio said it secured $100 million in financing transactions, including $75 million of non-dilutive funding under its existing revenue interest purchase agreement with Oberland Capital and a $25 ...

Flowers Foods said Terry Thomas, its chief growth officer, will step down and the role will be eliminated, ending a position created in 2023 to accelerate growth capabilities and build new ...

SiteOne Landscape Supply said Scott Salmon will retire March 31, 2026, ending a run that began in 2019 as executive vice president of strategy and development. The company named Daniel Laughlin, ...

Vor Biopharma recently released its 10-K report. The company described itself as a clinical-stage biopharmaceutical company focused on telitacicept, which it in-licensed in June 2025 from RemeGen for ...

McEwen said its Tartan mine project in Flin Flon, Manitoba now carries an estimated 308,900 indicated gold ounces and 302,700 inferred gold ounces, based on a gold price of US$3,000 an ounce. The ...

Maze Therapeutics has recently released its 10-K report. Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco that develops small-molecule precision ...

Merck agreed to buy Terns Pharmaceuticals for $53.00 a share in cash, valuing the clinical-stage oncology company at about $6.7 billion in equity value, or about $5.7 billion net of acquired cash. The ...

UiPath said Chief Technology Officer Raghu Malpani is taking on an expanded role as chief product and technology officer, effective March 25, 2026. Malpani joined UiPath in May 2024 as CTO, meaning he ...

Braze recently released its 10-K report. Braze, Inc. operates a customer engagement platform used by brands to manage messaging and data across mobile, web, email, and other channels. The company, ...

Dycom Industries has appointed Raejeanne Skillern to its board of directors, effective March 24, 2026. Skillern brings more than 30 years of experience across hyperscale cloud, data center ...

ADMA Biologics said March 27 that end-user demand for Asceniv has risen steadily over the past two-plus years and is now at a record high, as the company pushed back against a March 24 short report ...

DBV Technologies narrowed its cash burn outlook and ended 2025 with a much larger cash cushion after a year of heavier spending tied to its peanut patch program and launch preparation. The company ...